First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
Clinical trial NCT00389155 · COMPLETED
Trial details
- NCT number
- NCT00389155
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-01-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.